Medicenna to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
TORONTO and HOUSTON, April 18, 2023 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or “the Company”) (NASDAQ: MDNA TSX: MDNA), a clinical stage immunotherapy company, today announced that Dr. Fahar Merchant, President and CEO of Medicenna, will participate in a fireside chat and management will participate in one-on-one meetings at the 2023 Bloom Burton & Co. Healthcare Investor Conference, which is scheduled to take place at the Metro Toronto Convention Centre in Toronto from April 25-26, 2023.
Details on the fireside chat are as follows:
Further Information For further information about the Company please contact: Elizabeth Williams, Chief Financial Officer, 416-648-5555, [email protected] Media Contact For media inquiries, please contact: David Melamed, Account Supervisor, Russo Partners, 212-845-4225, [email protected]
Shortcuts to Seeking "Biden Bucks" â€¦Secrets to Writing a Bulletproof Grant Proposal
Keynote Presentation TBA
Securing the Cloud